EN | PT
With an academic degree in Pharmaceutical Sciences and a Post-Graduate degree in Pharmaceutical Management, he has assumed various leadership roles in entities operating in the pharmaceutical area, namely in the National Pharmacies' Association and National Pharmaceutical College. Furthermore, he was also a Technical Director and owner of pharmacies established in central Portugal and Director of Farbeira – a distribution co-op.
In 2001, he led a group of professionals that launched Bluepharma, after acquiring the industrial facilities previously owned by the multinational company Bayer, in Coimbra. His role was instrumental in defining the strategic path that led to the company's turn-around performance.
Aside from managing other companies, he is currently the chairman and Executive President of Bluepharma and Bluepharma Genéricos. He is also a member of Luzitin´s and A2B's administrative board.
With a degree in German and English Philology and a Post-graduate degree in European Law and Economics, both granted by the University of Coimbra, she is highly experienced in industrial management.
Her career has from early on been linked to Bayer, where she undertook several and progressively larger responsibilities, which helped her acquire solid expertise in the different aspects of running an industry. Having joined the company as a trainee, she later received formal training for two years in the company's headquarters in Germany. In 1990 she assumed the duties of General Director of Bayer's industrial unit in Coimbra. In 2001, her role was instrumental in managing the the transition from Bayer to the current Bluepharma, having contributed towards bringing together the german knowledge and accuracy and the dynamism of the new managing team.
With Bluepharma's launch, she became Head of Operations and is currently its Vice-President.
Sérgio Simões has a degree in Pharmaceutical Sciences, a Master degree in Chemical Engineering and a Ph.D. in Pharmaceutical Sciences.
He is currently the Head of R&D at Bluepharma and its Vice-President. He is also the Chairman of Luzitin. He has published more than 100 SCI journal papers, 7 book chapters and he is the author/co-author of 240 presentations in international conferences and workshops. Over the last years, he has conducted several research projects in the field of Biotechnology and gained significant expertise on the development, industrial technology transfer and manufacturing of pharmaceutical dosage forms for the European market.
He is founder/share-holder of other companies related to research, development and production of medicines, such as Pharmagen and Treat U.
With a degree in Pharmaceutical Sciences, his entrepreneurial expertise spans over several sector of activity.
He is currently member of Bluepharma and Bluepharma Genéricos' board, duties he performs while also presiding over Plural – a successful distribution cooperative, formerly known as Farbeira. He is also a certified pharmacist and owner of a pharmacy in Coimbra. Additionally, he is part of the administrative board of Farminveste SGPS S.A. He is highly experienced in corporate investment, noticeable in his involvement as a managing partner of MMS Investimentos, Sociedade Produtora de Café, A2B SGPS S.A. and M. Silvestre & Correia Dias. He is currently also the President of Finanfarma's General Assembly.
Together with his intense entrepreneurial activity, he is moreover an active member of the governing body of the National Pharmacies' Association, presiding over the Delegation of the Centre since 2000.
Miguel Botto has a degree in Business and post-graduate degrees in Finance and Strategic Management, obtained from Universitas Catholica in Lisbon,and in Leadership, granted by Harvard University.
He began his professional career in the tourism sector, as financial director and administrator. He took on academic responsibilities as well, as assistant professor of the BA and MBA business programs at the HEC School of the University of Lausanne and as co-chair professor at ESADE in Barcelona and invited lecturer at the University of Minho, Portugal.
He has been associated to venture capitalist activities since 1992, and is nowadays part of InovCapital's team. Moreover he is currently the Chairman of FiberSensing, member of the Board of Bluepharma, Bluepharma Genéricos and Enoforum. Among other responsibilities, he was also member of the board of Altitude, Micropolis, Cotflax and President of the Fiscal Council of Térmica Portuguesa.
